Organization

Upeclin HC FM Botucatu Unesp

1 clinical trial

Clinical trial

Randomized, Prospective, Controlled, Single-center, Open-label Phase II Clinical Trial Aimed at Evaluating the Safety and Efficacy of Autologous Mesenchymal Stem Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia

Status: Not yet recruiting, Estimated PCD: 2027-07-01